EOLO PHARMA Announces Regulatory Clearance To Initiate Phase 1 Study Of MVD1 For Obesity And Type 2 Diabetes
olimpo.tech
19 de May de 2023
No Comments
EOLO PHARMA announced that it has received approval to initiate a Phase 1 clinical
